491 related articles for article (PubMed ID: 17364281)
1. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
Kahila H; Saisto T; Kivitie-Kallio S; Haukkamaa M; Halmesmäki E
Acta Obstet Gynecol Scand; 2007; 86(2):185-90. PubMed ID: 17364281
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
4. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
[TBL] [Abstract][Full Text] [Related]
5. [Substitution treatment of drug addicts during pregnancy: consequences for the children?].
Sandtorv L; Reigstad H; Bruarøy S; Elgen I; Laegreid LM
Tidsskr Nor Laegeforen; 2009 Feb; 129(4):287-90. PubMed ID: 19219093
[TBL] [Abstract][Full Text] [Related]
6. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
7. [Infants of drug-addicted mothers: pitfalls of replacement therapy].
Vert P; Hamon I; Hubert C; Legagneur M; Hascoet JM
Bull Acad Natl Med; 2008 May; 192(5):961-9; discussion 969. PubMed ID: 19238786
[TBL] [Abstract][Full Text] [Related]
8. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy.
Schindler SD; Eder H; Ortner R; Rohrmeister K; Langer M; Fischer G
Addiction; 2003 Jan; 98(1):103-10. PubMed ID: 12492761
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy under high-dose buprenorphine.
Simmat-Durand L; Lejeune C; Gourarier L;
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):119-23. PubMed ID: 19058904
[TBL] [Abstract][Full Text] [Related]
10. Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine.
Sarfi M; Martinsen H; Bakstad B; Røislien J; Waal H
Early Hum Dev; 2009 Dec; 85(12):773-8. PubMed ID: 19931991
[TBL] [Abstract][Full Text] [Related]
11. Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero.
Hytinantti T; Kahila H; Renlund M; Järvenpää AL; Halmesmäki E; Kivitie-Kallio S
Acta Paediatr; 2008 Aug; 97(8):1040-4. PubMed ID: 18474065
[TBL] [Abstract][Full Text] [Related]
12. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
13. [Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases].
Lejeune C; Aubisson S; Simmat-Durand L; Cneude F; Piquet M; Gourarier L;
Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():21-7. PubMed ID: 11965095
[TBL] [Abstract][Full Text] [Related]
14. [Buprenorphine in pregnancy].
Eder H; Rupp I; Peternell A; Fischer G
Psychiatr Prax; 2001 Sep; 28(6):267-9. PubMed ID: 11533891
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
Debelak K; Morrone WR; O'Grady KE; Jones HE
Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
[TBL] [Abstract][Full Text] [Related]
17. Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
[TBL] [Abstract][Full Text] [Related]
18. [Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept].
Rohrmeister K; Bernert G; Langer M; Fischer G; Weninger M; Pollak A
Z Geburtshilfe Neonatol; 2001; 205(6):224-30. PubMed ID: 11745008
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine withdrawal syndrome in a newborn.
Marquet P; Chevrel J; Lavignasse P; Merle L; Lachâtre G
Clin Pharmacol Ther; 1997 Nov; 62(5):569-71. PubMed ID: 9390114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
